chr17-77281351-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000589070.1(SEPTIN9):c.31+545T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0367 in 536,186 control chromosomes in the GnomAD database, including 442 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.035 ( 101 hom., cov: 27)
Exomes 𝑓: 0.037 ( 341 hom. )
Consequence
SEPTIN9
ENST00000589070.1 intron
ENST00000589070.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.459
Genes affected
SEPTIN9 (HGNC:7323): (septin 9) This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 17-77281351-T-G is Benign according to our data. Variant chr17-77281351-T-G is described in ClinVar as [Benign]. Clinvar id is 1255034.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0349 (4429/126886) while in subpopulation NFE AF= 0.0477 (2921/61218). AF 95% confidence interval is 0.0463. There are 101 homozygotes in gnomad4. There are 2156 alleles in male gnomad4 subpopulation. Median coverage is 27. This position pass quality control queck.
BS2
High AC in GnomAd4 at 4429 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEPTIN9-DT | NR_136503.1 | n.286+261A>C | intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0349 AC: 4432AN: 126854Hom.: 101 Cov.: 27
GnomAD3 genomes
AF:
AC:
4432
AN:
126854
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0373 AC: 15263AN: 409300Hom.: 341 AF XY: 0.0365 AC XY: 7886AN XY: 216026
GnomAD4 exome
AF:
AC:
15263
AN:
409300
Hom.:
AF XY:
AC XY:
7886
AN XY:
216026
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0349 AC: 4429AN: 126886Hom.: 101 Cov.: 27 AF XY: 0.0358 AC XY: 2156AN XY: 60216
GnomAD4 genome
AF:
AC:
4429
AN:
126886
Hom.:
Cov.:
27
AF XY:
AC XY:
2156
AN XY:
60216
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 21, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at